EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients
Ngày 01/07/2022 08:07 | Lượt xem: 757

Results from the first commercial implants of the Trilogy transcatheter aortic valve implantation (TAVI) system (Jenavalve) for high-surgical risk patients with severe, symptomatic aortic stenosis (AS) or aortic regurgitation (AR) were reported at EuroPCR 2022 (17–20 May, Paris, France)

Matti Adam (University Hospital Cologne, Cologne, Germany) reported the first 28 commercial implants of the Trilogy system for AS across six high-volume German centres. In Adam’s series, all patients presented with severe AS. At baseline, 61% of the patients presented with New York Heart Association class III or IV heart failure (NYHA III/IV), and 29% had a left ventricular ejection fraction (LVEF) of less than or equal to 50%.

The outcomes were positive, achieving 100% technical success, zero conversions to open surgery, zero new permanent pacemakers, and one patient death, which was non-device related, Adam reported. Post-operatively, 86% of the patients had none or trace paravalvular regurgitation (PVL) and no incidence of moderate or greater PVL.

“The JenaValve Trilogy is specifically and uniquely designed with locators that align the valve with the native cusps providing excellent commissural alignment with easy access to the coronary arteries, and form a secure seal for minimal PVL,” said Adam. “Given the unique design, we are seeing very positive results in AS patients, as well as in the AR cohort.”

Alexander R Tamm (Johannes Gutenberg-Universität, Mainz, Germany) presented data on 45 AR patients from the same six German heart centres. In this series, all patients presented with moderate-severe or severe AR.

Alexander Tamm at EuroPCR 2022

At baseline, 71% of the patients presented with NYHA III/IV, and 58% had an LVEF less than or equal to 50%. The outcomes of the AR series were also positive, with technical success achieved in all patients. There were no conversions to open surgery, stroke, or death. Post-operatively, 92% of the patients had none or trace PVL and nine patients required a new pacemaker.

Of the patients requiring a pacemaker, at least 33% of the patients had pre-existing conduction system abnormalities.

“Before Trilogy’s CE mark approval, TAVI for AR was performed off-label using devices designed for aortic stenosis—which posed procedural challenges with poorer outcomes,” said Tamm. “The Trilogy valve is a game-changer, which delivers solid anchoring and commissural alignment due to the locator technology while also limiting protrusion into the left ventricle. Additionally, the haemodynamics are the best in class.”

Source CardiovascularNews

Duc Tin CLinic

Print Chia sẽ qua facebook bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua google bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua twitter bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua MySpace bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua LinkedIn bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua stumbleupon bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua icio bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua digg bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua yahoo bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua yahoo bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua yahoo bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients Chia sẽ qua yahoo bài: EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP